4 Consumer Non-Durables Stocks Dragging The Industry Down

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 16,456 as of Friday, Jan. 3, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,718 issues advancing vs. 1,181 declining with 172 unchanged.

The Consumer Non-Durables industry currently is unchanged today versus the S&P 500, which is unchanged.

TheStreet would like to highlight 4 stocks pushing the industry lower today:

4. Domtar ( UFS) is one of the companies pushing the Consumer Non-Durables industry lower today. As of noon trading, Domtar is down $2.91 (-3.1%) to $90.88 on average volume. Thus far, 156,171 shares of Domtar exchanged hands as compared to its average daily volume of 317,700 shares. The stock has ranged in price between $90.79-$92.24 after having opened the day at $91.93 as compared to the previous trading day's close of $93.79.

Domtar Corporation designs, manufactures, markets, and distributes communications papers, specialty and packaging papers, and adult incontinence products worldwide. It operates in three segments: Pulp and Paper, Distribution, and Personal Care. Domtar has a market cap of $3.0 billion and is part of the consumer goods sector. Shares are down 0.6% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Domtar a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Domtar as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Domtar Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Owens-Illinois ( OI) is down $0.83 (-2.3%) to $34.70 on average volume. Thus far, 552,859 shares of Owens-Illinois exchanged hands as compared to its average daily volume of 976,900 shares. The stock has ranged in price between $34.48-$35.02 after having opened the day at $34.88 as compared to the previous trading day's close of $35.53.

Owens-Illinois, Inc., through its subsidiaries, manufactures and sells glass container products to food and beverage manufacturers primarily in Europe, North America, South America, and the Asia Pacific. Owens-Illinois has a market cap of $5.9 billion and is part of the consumer goods sector. Shares are down 0.7% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Owens-Illinois a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Owens-Illinois as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, notable return on equity, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Owens-Illinois Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Nu Skin ( NUS) is down $4.31 (-3.1%) to $133.76 on average volume. Thus far, 770,594 shares of Nu Skin exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $132.85-$139.15 after having opened the day at $139.15 as compared to the previous trading day's close of $138.07.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands worldwide. Nu Skin has a market cap of $8.2 billion and is part of the consumer goods sector. Shares are down 0.1% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Nu Skin a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Nu Skin as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Nu Skin Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Herbalife ( HLF) is down $4.23 (-5.3%) to $75.60 on heavy volume. Thus far, 3.6 million shares of Herbalife exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $75.55-$78.99 after having opened the day at $78.53 as compared to the previous trading day's close of $79.83.

Herbalife Ltd., through its subsidiaries, produces and distributes weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products worldwide. Herbalife has a market cap of $7.9 billion and is part of the consumer goods sector. Shares are up 1.4% year to date as of the close of trading on Thursday. Currently there are 5 analysts that rate Herbalife a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Herbalife as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Herbalife Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the consumer non-durables industry could consider Consumer Staples Select Sector SPDR ( XLP) while those bearish on the consumer non-durables industry could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2